Healthcare and technology start-ups remain hot property, but pandemic-fuelled uncertainty has led to lower valuations in some areas, such as travel-related platforms.
More asset owners are looking to support healthcare private equity funds amid the pandemic. But aspiring funds also face rising competition, increasing asset costs and geopolitical risk.
State wealth funds look set to invest more at home thanks to the pandemic, but their increased allocations to healthcare and tech should prove beneficial, says a new report.
The firm's investment head for Asia says it's hard to find pure-play products for robotics and and cyber-security, which are both increasingly popular themes among clients.
Private equity firms in Greater China are exploiting the valuation differentials between China and markets such as the US, as well as between private and public markets.
China and India spend just 3% of GDP on healthcare, as against 16% in the US, but that figure is set to grow far faster than in developed markets, says Andy Acker of Janus Capital.
HSBC Global AM appoints new Asia fixed income chiefs; PAG names Japan PE co-heads; EquitiesFirst names Beijing office head; Noah Holdings CIO resigns; Pictet replaces Singapore chief; HKEX names interim CEO; Tahnoon Pasha departs Spencer Stuart and Asia; Newton IM poaches Aviva Investors' CEO.
Experts say the country's debut sovereign wealth fund needs full investing independence to attract international assets, but this appears unlikely according to current plans.
Capital Group names new Japan president; Robeco replaces Singapore chief; Hillhouse Capital hires ex-Blackstone MD; Vontobel expands EM debt team; HSBC Global AM names Apac ETF sales head; Manulife creates new digital business role; Stanchart names CIO for wealth management; TMF appoints fund services exec in Shanghai; and more.
Australia's MLC Life gets capital from Nippon Life and NAB; Ping An to buy properties from Agile Group; KIC names heads of alts and private equity; NPS appoints Russell Investments for $1b real estate mandate; CDPQ co-invests in $2.7b Taiwan offshore wind farm deal; GIC makes first Vietnam healthcare investment and more.
In a recent webinar, AsianInvestor spoke to top experts on emerging market (EM) corporate debt to get a better sense of the opportunities, risks and rewards that investors should be familiar with. To continue the conversation, we followed up with panelists to further explore some key issues.
The number of lenders reducing their Asian exposure is seen to be growing fast amid the coronavirus crisis, leaving asset managers keen to fill the financing gap.
The past year has seen something of a growth spurt for green bonds, with the market heading toward the $1 trillion milestone, according to data from the Climate Bonds Initiative and Bloomberg. It has also seen the emergence of social bonds, used for social investments with aims such as expanding access to healthcare and education. As well as significant government bond launches, there has been increased issuance from the corporate sector and from a wider range of businesses and industries.
While sustainable investment themes and practices are making steady in-roads across the region, the pace would increase with greater asset choice and standardised data, finds the latest AsianInvestor / S&P Dow Jones Indices ESG poll.